[Start of Market Research Report Handling] World Market Report on Saliva Collection and Diagnosis 2022-2032

The global market for saliva collection and diagnostics is poised for significant growth, with an estimated valuation of $780 million in 2023, projected to reach $1.18 billion by 2032, and a CAGR of 4.7% during the forecast period.
This rapid growth is attributed to advancements in non-invasive diagnostic technologies, increased awareness of saliva-based testing, and innovations in sample collection devices.
The COVID-19 pandemic highlighted the potential of saliva as an effective sample type for diagnostic applications, including infectious disease testing, acting as a major catalyst. The non-invasive nature of saliva collection methods, combined with technological innovations like the SpeciMAX Stabilized Saliva Collection Kit, further propelled market adoption. Additionally, the expansion of saliva-based diagnostics into segments such as hormone monitoring, stress analysis, and chronic disease detection, beyond COVID-19, supports the growing preference for this sample type over traditional blood tests.
■ Published by Bizwit Research & Consulting LLP

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration